Glenn Speirs

Glenn Speirs has extensive work experience in financial planning and analysis roles. Glenn is currently the Director of Financial Planning and Analysis at AnaptysBio since July 2022. Prior to this, they worked as the Associate Director of Financial Planning and Analysis at AnaptysBio from July 2019 to June 2022. From 2014 to 2019, they served as the Director of Financial Planning & Analysis at Pfenex Inc, where they built a robust corporate financial model and led the evaluation and implementation of enterprise performance management software. Before that, they were the Director of Financial Planning & Analysis at Amylin Pharmaceuticals (now AstraZeneca) from 2005 to 2014, where they led budgeting and forecasting processes for significant development program spending. Glenn also worked as the Plant Controller at Ionis Pharmaceuticals, Inc. from 2003 to 2005, where they implemented a standard costing system and streamlined accounting processes. Glenn's earlier experience includes roles at Callaway Golf, where they served as the Senior Financial Analyst, Controller of Callaway Golf Ball Company, and Controller of Odyssey Golf.

Glenn Speirs holds a Bachelor's Degree in Accounting from Colorado State University. Glenn has also obtained additional certifications, including CPA (Inactive) from the State of California and Maximizing Your Leadership Potential from the Center for Creative Leadership. No specific information regarding the start and end years of their education or the months and years of obtaining the certifications is provided.